Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Outlook Highlighting Key Drivers And Market Evolution
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market From 2026 To 2030?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market has experienced significant expansion in its size over recent years. This market is projected to expand from $0.68 billion in 2025 to $0.75 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this expansion has stemmed from several key factors, including the rising incidence of sexually transmitted infections, the inherent drawbacks of conventional diagnostic approaches, heightened awareness regarding women’s reproductive well-being, the proliferation of clinical diagnostic laboratories, and the widespread implementation of standard pcr testing protocols.
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of $1.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected growth is driven by several factors, including an increasing need for point-of-care molecular diagnostics, progress in multiplex and real-time pcr technologies, a surge in the use of home-based testing options, greater investments in molecular diagnostic infrastructure, and the expansion of screening initiatives for sti and vaginitis. Key trends foreseen for this period encompass a rise in the uptake of multiplex pcr panels for detecting sti and vaginitis, a growing inclination towards rapid and highly sensitive molecular diagnostic methods, an escalating requirement for at-home and self-collected pcr testing kits, broader implementation of pcr testing within routine women’s health screening, and a heightened emphasis on identifying pathogens both early and precisely.
Access Your Free Sample Report For In-Depth Market Analysis:
What Significant Factors Are Influencing The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Expansion?
The increasing sexual health screenings are expected to propel the growth of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market going forward. Sexual health screenings involve medical tests conducted to detect sexually transmitted infections (STIs) and other related conditions, ensuring early diagnosis, treatment, and prevention of disease spread. These screenings are on the rise due to the growing global prevalence of sexually transmitted infections, which has intensified the need for early detection and timely treatment to prevent complications and reduce infection transmission. Sexual health screenings play a crucial role in STI and vaginitis PCR testing by facilitating early and precise identification of various infections, often even in the absence of symptoms, thereby supporting prompt treatment and helping prevent complications and the spread of infections. For instance, in July 2025, according to the Bristol City Council, a UK-based government agency, in 2024, sexual health services conducted 25,410 STI tests (excluding chlamydia screening for people under 25), equating to 5,260.9 tests per 100,000 population. This rate exceeds the England average of 4,088.8 per 100,000. Therefore, the increasing sexual health screenings are driving the growth of the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market.
How Is The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Categorized Across Its Segment Groups?
The sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market covered in this report is segmented –
1) By Test Type: Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels, Vaginitis Polymerase Chain Reaction (PCR) Panels
2) By Condition: Sexually Transmitted Infections, Vaginal Infections
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Homecare Or At-Home Testing, Other End Users
Subsegments:
1) By Sexually Transmitted Infection (STR) Polymerase Chain Reaction (PCR) Panels: Chlamydia Trachomatis Polymerase Chain Reaction, Neisseria Gonorrhoeae Polymerase Chain Reaction, Trichomonas Vaginalis Polymerase Chain Reaction, Herpes Simplex Virus Polymerase Chain Reaction, Human Papillomavirus Polymerase Chain Reaction, Mycoplasma Genitalium Polymerase Chain Reaction, Syphilis Polymerase Chain Reaction, Multiplex Sexually Transmitted Infection Polymerase Chain Reaction Panels
2) By Vaginitis Polymerase Chain Reaction (PCR) Panels: Bacterial Vaginosis Polymerase Chain Reaction, Candida Species Polymerase Chain Reaction, Trichomoniasis Polymerase Chain Reaction, Mixed Vaginitis Polymerase Chain Reaction Panels, Aerobic Vaginitis Polymerase Chain Reaction, Atrophic Vaginitis Polymerase Chain Reaction
What Trends Are Affecting The Direction Of The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
Major companies in the sexually transmitted infection (STI) and vaginitis PCR testing market are developing advanced technologies, specifically multiplex real-time PCR assays, to address the growing need for rapid, precise, and broad pathogen identification. This multiplex PCR approach allows for the concurrent amplification and identification of DNA or RNA from various pathogens within a single test, thereby cutting down both the processing time and expenses when compared to traditional single-pathogen assays. Furthermore, this method enhances sensitivity and specificity, making it possible to detect even minute quantities of pathogen genetic material, including in co-infections, which conventional culture or microscopy techniques might overlook or identify less accurately. An illustration of this progress is Thermo Fisher Scientific, a US-based biotechnology firm, which introduced the Applied Biosystems TrueMark STI Select Panel in February 2023. This multiplex real-time PCR assay is engineered to identify four prevalent STIs simultaneously: Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Designated for research purposes, this test contributes to better clinical outcomes through quicker, highly sensitive diagnostic results while optimizing laboratory operations, marking a notable step forward in molecular STI diagnostics.
Which Firms Are Influencing Competition In The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market?
Major companies operating in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Hologic Inc., QIAGEN N.V., ARUP Laboratories Inc., Seegene Inc., LetsGetChecked Ltd., Sansure Biotech Inc., Visby Medical Inc., R-Biopharm AG, Savyon Diagnostics Ltd., altona Diagnostics GmbH, SpeeDx Pty Ltd., CERTEST BIOTEC S.L., ALPCO Diagnostics, Atila Biosystems Inc., Ridacom Diagnostics Ltd., Sinochips Diagnostics Co Ltd., Vitassay S.L., Bioperfectus Technologies Co. Ltd.
Get The Full Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Report:
Where Is The Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Most Concentrated Geographically?
North America was the largest region in the sexually transmitted infection (STI) and vaginitis polymerase chain reaction (PCR) testing market in 2025. The regions covered in the sexually transmitted infection (sti) and vaginitis polymerase chain reaction (pcr) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Sexually Transmitted Infection (STI) And Vaginitis Polymerase Chain Reaction (PCR) Testing Market 2026, By The Business Research Company
Motor Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report
Car Insurance Aggregators Market Report 2026
https://www.thebusinessresearchcompany.com/report/car-insurance-aggregators-global-market-report
Automotive Usage Based Insurance Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
